Otofarma SpA (MIL:OTO) Revenue: € Mil (TTM As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.76
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Revenue?

Otofarma SpA MIL:OTO -1.43% 16 Revenue is € Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's revenue for the six months ended in Dec. 2024 was €15.20 Mil. Otofarma SpA does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in Dec. 2024. Otofarma SpA's Revenue per Share for the six months ended in Dec. 2024 was €2.64. Otofarma SpA does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024.

During the past 12 months, the average Revenue per Share Growth Rate of Otofarma SpA was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Otofarma SpA  (MIL:OTO) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Otofarma SpA Revenue Related Terms

Otofarma SpA Revenue Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Revenue Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Revenue
12.06 15.20

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Revenue 12.06 15.20

MIL:OTO vs ABT, SYK, MDT: Revenue Comparison

For the Medical Devices subindustry, Otofarma SpA's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Otofarma SpA Revenue vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's Revenue distribution charts can be found below:

* The bar in red indicates where Otofarma SpA's Revenue falls into.


MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of € Mil mean?
Otofarma SpA (MIL:OTO) has a Revenue of € Mil as of Dec. 2024. Revenue is the total amount a company generates as sales through its operations. View historical data on Otofarma SpA and its competitors.
Is Otofarma SpA's Revenue too high?
Otofarma SpA's current Revenue is € Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Revenue compare to ABT and SYK?
Otofarma SpA's Revenue of € Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current Revenue is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Revenue of € Mil. The current Revenue is € Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Revenue is € Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.76
Price